ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Alzheimer Disease

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

COVID-19

Cannabis

Case Discussions

Child & Adolescent Psychiatry

Climate Change

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Digital Therapeutics

Diversity, Equity, Inclusion

Drug Watch

Eating Disorders

Emergency Psychiatry

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Media & Psychiatry

Mental Health Awareness Month

Mood Disorders

Cognitive Disorders

Dementia

Autism

Neuropsychiatry

PTSD

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Postpartum Depression

Psychedelics

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Sports Psychiatry

Suicide

Tardive Dyskinesia

Technology & Psychiatry

Transcranial Magnetic Stimulation

News

Media

Peer Exchange

Case-Based Psych Perspectives

Clinical Case Collective

Insights

Peers & Perspectives

Slideshows

Videos

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Between the Lines

Expert Perspectives

Clinical Consult

Clinical Scales

Interactive Tools

Partner Perspectives

Quizzes

Series

Special Reports

Subscribe

Articles

Onfasprodil shows promise as a rapid treatment for resistant depression, offering fewer side effects than ketamine in recent clinical trials.

Investigational Agent in Proof-of-Concept Trial Shows Rapid Improvement of Treatment-Resistant Depression

is an outpatient psychiatrist at Prisma Health-Upstate and clinical associate professor at the University of South Carolina School of Medicine, Greenville. He served on the American Psychiatric Association’s Task Force to Address Structural Racism Throughout Psychiatry, and he currently serves as the Diversity and Inclusion section editor and advisory board member for

Reflections on Resilience

is assistant professor in the department of otorhinolaryngology at Graduate School of Medical Sciences in Kyushu University, Fukuoka, Japan. He is a board member of the Japan Society for Stuttering and other Fluency Disorders (JSSFD), the Japanese Development Chair of the World Stuttering Network (WSN), and the secretary of the Stuttering Treatment and Research Society (STARS).

Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.

Childhood-Onset Fluency Disorder: Perspectives on Comorbid Anxiety and Stuttering

FDA clears accelerated deep TMS protocol for major depressive disorder, offering faster treatment with similar outcomes and fewer visits.

FDA Clears Accelerated Protocol for Deep TMS to Treat Major Depressive Disorder

Psychiatric Times is the connection to Psychiatry and Mental Health, featuring clinical updates, expert views, and research news in multimedia formats.

About

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Psychiatric Times - Mental Health News, Clinical Insights

Facebook

LinkedIn

Spotlight

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales from the New Asylum

1rem

Continuing Medical Education

In this CME, learn about the convergence of neuroscience and spirituality.

Psychiatry and Spirituality: Exploring the Intersections of Meaning and Mental Health

In this CME article, discover effective strategies for prescribing MAOIs in treating major depressive disorder.

Successfully Prescribing MAOIs for Depression

In this CME article, learn more about the complexities of neuropsychiatric symptoms in Parkinson disease, including psychosis and cognitive impairment, and effective treatment strategies.

Impulse Control Disorders, Psychosis, and Cognitive Impairment in Parkinson Disease

In this CME article, learn more about the essential role of MAOIs in treating resistant depression and anxiety.

Understanding and Overcoming Negative Preconceptions About MAOIs

In this CME article, explore the complexities of Parkinson disease, focusing on neuropsychiatric symptoms, their prevalence, and effective treatment strategies for improved patient care.

Depression, Apathy, and Anxiety in Parkinson Disease

In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.

Post-Acute Sequelae of COVID-19 Infection Presenting With Neuropsychiatric Symptoms: Diagnosis and Management

In this CME article, learn more about the opportunity for collaboration with dermatologist, psychologist, and social worker peers to improve patient mental health.

Psychodermatology: An Opportunity for Collaboration Among Health Care Professionals

In this CME article, learn more about alternative methods to screen for lithium-related polyuria and how to implement amiloride for lithium-related polyuria. 

Demystifying Lithium Therapy—A Primer for Clinicians: Lithium-Related Polyuria, Part 2

In this CME article, learn more about recent developments with lithium as they relate to renal issues.

Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

In this CME article, learn more about a protocolized approach to the hospital management of pediatric patients with severe malnutrition related to eating disorders, including the utilization of a multidisciplinary care team and structured psychoeducation materials for families.

Multidisciplinary Inpatient Care for Medically Compromised Youth and Young Adults With Eating Disorders

Daniel Claassen, MD, MS; Martha A. Nance, MD

 Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

Ilan Melnick, MD; Alejandro Alva, MD; Linda Trinh, DNP, PMHNP, FNP, MPH

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Southern Florida Psychiatry Conference

Real Psychiatry 2026

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Optimizing Care for Patients With Tardive Dyskinesia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

(CME Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(Pharmacist Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Upcoming CME Events & Activities

EVENTS

ACTIVITIES